Skip to main content
Clinical Trials/CTRI/2021/04/032544
CTRI/2021/04/032544
Completed
未知

A Prospective, Multicentric Study to Evaluate the Prevalence of Hypogonadism in Indian Male Patients Suffering from Type 2 Diabetes with or without Obesity

Abbott Healthcare Pvt Ltd0 sites600 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Health Condition 1: E35- Disorders of endocrine glands in diseases classified elsewhere
Sponsor
Abbott Healthcare Pvt Ltd
Enrollment
600
Status
Completed
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
3 years ago
Study Type
Observational

Investigators

Eligibility Criteria

Inclusion Criteria

  • 1\)Males from 30 years to 65 years of age with
  • Known cases of type 2 diabetes mellitus \> 5 years duration with or without obesity.

Exclusion Criteria

  • 1\.Use of androgen therapy or anabolic steroids within 12 weeks of entry into the study.
  • 2\.History or current diagnosis of breast or prostate cancer.
  • 3\.Patients with known causes of hypogonadism (e.g. Klinefelterââ?¬•s syndrome,
  • uncorrected cryptorchidism, surgical orchiectomy, or prior infectious orchitis)
  • 4\.T1DM, suffering from any known chronic liver disease, renal disease, advanced malignancy,
  • debilitating diseases such as tuberculosis, malabsorption, inflammatory bowel disease, pyrexia of unknown origin, acquired immunodeficiency syndrome, sickle cell disease, autoimmune diseases such as rheumatoid arthritis, ankylosing spondylitis, any inflammatory disease or infection, and
  • already receiving hormone replacement therapy or with severe psychological symptoms.

Outcomes

Primary Outcomes

Not specified

Similar Trials